Skip to main content
. 2021 May 17;5:41. doi: 10.1038/s41698-021-00181-4

Fig. 2. Distinct patterns of CXCL10 and IL6 induction in EGFR mutant lung cancer cell lines treated with osimertinib.

Fig. 2

Media from PC9, H1650, HCC4006, and HCC827 cells treated with 300 nM osimertinib or DMSO control for the indicated time points was collected and submitted to ELISA measurements of CXCL10 and IL6 protein. The data are the mean and SEM of three independent experiments.